KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Capital Expenditures (2016 - 2025)

Rigel Pharmaceuticals has reported Capital Expenditures over the past 15 years, most recently at -$12000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 146.15% year-over-year to -$12000.0; the TTM value through Dec 2025 reached $276000.0, up 9.52%, while the annual FY2024 figure was $36000.0, N/A changed from the prior year.
  • Capital Expenditures for Q4 2025 was -$12000.0 at Rigel Pharmaceuticals, down from $26000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $407000.0 in Q2 2021 and troughed at -$36000.0 in Q2 2022.
  • A 4-year average of $109100.0 and a median of $72000.0 in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 1025.0% in 2021 and later tumbled 146.15% in 2025.
  • Year by year, Capital Expenditures stood at -$21000.0 in 2021, then skyrocketed by 447.62% to $73000.0 in 2022, then tumbled by 64.38% to $26000.0 in 2024, then tumbled by 146.15% to -$12000.0 in 2025.
  • Business Quant data shows Capital Expenditures for RIGL at -$12000.0 in Q4 2025, $26000.0 in Q4 2024, and $73000.0 in Q4 2022.